Effect of betulinic acid on proliferation of human gastric cancer MGC-803 cell line

doi:10.12047/j.cjap.6066.2021.020

Abstract

Abstract: Objective: To investigate the effect of betulinic acid on the proliferation of human gastric cancer MGC-803 cells in vitro. Methods: Human gastric cancer MGC-803 cells were divided into 4 groups, each with 3 multiple holes. Control cells add betulinic acid at a concentration of 0 μg /ml, and the other three experimental groups were added with final concentration of 10, 20, 30 μg/ml Betulinic acid respectively. Cells in each group were incubated in a 5% CO₂ incubator for 48 hours, and the Giemsa staining method and trypan blue exclusion method were used to detect the effect of betulinic acid on the cell clone formation rate and growth inhibition rate; EdU method and flow cytometry were used to detect cell proliferation and cell cycle changes; qRT-PCR and Western blot were used to detect the expressions of cell cycle regulators CCNB1 and CCND1. Results: Compared with the control group, the clone formation rate of human gastric cancer MGC-803 cells was significantly reduced (P＜0.01), the growth inhibition rate was significantly increased, and the cell proliferation ability was significantly decreased (P＜0.01); with the increase of betulinic acid concentration in each experimental group the proportion of cells in the G1 phase was gradually decreased, and the number of cells in S phase was increased significantly (P＜0.01); the mRNA and protein expression levels of cell cycle regulators CCNB1 and CCND1 were decreased significantly, and the 30 μg/ml betulinic acid treatment group performed best. Conclusion: At a final concentration of 10～30 μg/ml, betulinic acid can reduce the proliferation of human gastric cancer MGC-803 cells, inhibit cell growth, and down-regulate the expression of CCNB1 and CCND1 to block human gastric cancer MGC-803 cells in the S phase.

Key words: betulinic acid, MGC-803 cells, cell proliferation, cell cycle regulator

CLC Number:

Q291

LIU Jiu-peng, SHAO Shu-li, HE Meng-qi, HUANG Xin, ZHANG Wei-wei, ZHANG Zhen-zhu CHEN Ya-nan. Effect of betulinic acid on proliferation of human gastric cancer MGC-803 cell line[J]. CJAP, 2021, 37(3): 257-261.

References 17

[1]	李玉龙, 王萍, 邱婷, 等. miR-195对胃癌MKN45细胞生物学行为的影响[J]. 山西医科大学学报, 2019, 50(11): 1505-1509.
[2]	徐瑞华, 滕开原. 晚期胃癌化疗进展[J]. 癌症, 2009, 28(10): 1108-1113.
[3]	王成双, 佐满珍. 华蟾素联合顺铂对卵巢癌细胞A2780增殖及凋亡的影响[J]. 肿瘤学杂志, 2017, 23(1): 30-34.
[4]	李雨颖, 邵喜英, 金莉婷, 等. 川楝素通过Fas/FasL信号通路诱导人卵巢癌细胞凋亡[J]. 中国中西医结合杂志, 2019, 39(9): 1089-1094.
[5]	樊蓓, 李红霞, 吴玉梅, 等. 小分子干扰RNA抑制TNC基因的表达并逆转卵巢癌紫杉醇耐药[J]. 癌症进展, 2017, 15(7): 749-753.
[6]	潘晶晶, 周含煜, 汪舸, 等. 桦木酸对胰腺癌细胞增殖影响及其机制探讨[J]. 中华肿瘤防治杂志, 2019, 26(6): 385-388.
[7]	陈飞宇, 李澎, 甘加宽, 等. 桦木酸对人肝癌HepG2肿瘤干细胞增殖的影响[J]. 中国中医药信息杂志, 2017, 24(2): 60-64.
[8]	吴海霞, 艾克白尔·买买提, 王帅, 等. 桦木酸通过抑制STAT3的活化提高胰腺癌细胞对吉非替尼的敏感性[J].中国肿瘤生物治疗杂志, 2019, 26(9): 948-954.
[9]	LiuWP, Li SL, Qu ZL, et al. Betulinic acid induces autophagy-mediated apoptosis through suppression of the PI3K/AKT/mTOR signaling pathway and inhibits hepatocellular carcinoma[J]. Am J Transl Res, 2019, 11(11): 6952-6964.
[10]	Tan ZY. Recent advances in the surgical treatment of advanced gastric cancer: A review[J]. Med Sci Monit, 2019, 25: 3537-3541.
[11]	翟军厚, 陈凤军. 化疗与生物免疫疗法治疗胃癌的疗效及对循环肿瘤细胞(CTC)的影响[J]. 中国现代医生, 2017, 55(12): 25-27.
[12]	赵翔宇, 何振宇, 宰守峰. 人参皂苷Rg5对胃癌细胞周期和侵袭的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(1): 51-55.
[13]	杜洋, 邵淑丽, 焦凯贺, 等. 白花蛇舌草对人胃癌细胞MNK-45线粒体膜电位及凋亡相关基因表达的影响[J]. 中国应用生理学杂志, 2020, 36(2): 171-175.
[14]	何恒, 虞玉存, 何咏, 等. Fibulin-5对膀胱癌细胞克隆形成能力及细胞中ROS、MMPs水平的影响[J]. 现代肿瘤医学, 2019, 27(8): 1308-1314.
[15]	卢梦玲, 闫超, 赖多, 等. Cyclin D1与细胞周期调控[J]. 生物技术通报, 2011(10): 55-59.
[16]	Zhang HY. CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy[J]. Hum Cell, 2020, 33(7): 140-147.
[17]	Shi Q, Wang WP, Jia ZQ, et al. ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth[J]. Oncotarget, 2016, 7(24): 36489-36500.